Skip to content

Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer

Integrated Analysis of Multi-center Cohorts and Bulk RNA-sequencing Data Reveal Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06040021
Enrollment
15244
Registered
2023-09-15
Start date
2008-01-01
Completion date
2023-06-30
Last updated
2023-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early-onset Colorectal Cancer, Late-onset Colorectal Cancer

Brief summary

The clinical and pathological features of early-onset colorectal cancer (EOCRC) differ from those of late-onset colorectal cancer (LOCRC). Our research aims to thoroughly elucidate the distinctions between them by analyzing clinical prognosis, metastatic patterns, gene expression, and genomic mutation profiles. Our deliberation will uncover latent strategies for personalized therapeutic of both EOCRC and LOCRC.

Interventions

Patients enrolled in these 2 cohorts all received standardized treatment of colorectal cancer.

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* The initial diagnosis of colonoscopy and pathology belongs to colorectal cancer; * Patients should sign an informed consent form after fully understanding the purpose, procedures and potential risks of the study, indicating their voluntary participation in the research.

Exclusion criteria

* Patients with obvious local or systemic severe infection; * Acute abdomen: intestinal obstruction, peritonitis, intestinal perforation; * Have a systemic underlying disease that has not been controlled, or is unstable; * Patients with poor physical fitness or serious other organic diseases who cannot tolerate anesthesia and surgery; * Women during pregnancy, perinatal and lactation; * Patients with severe mental disorders (such as schizophrenia, bipolar disorder, etc.) or patients who are mentally incapable or unable to understand the requirements for participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
OS5 years after interventionoverall survival

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026